Insmed Inc Stock Performance
| INSM Stock | USD 23.78 0.16 0.67% |
Insmed has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.4433, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Insmed returns are expected to increase less than the market. However, during the bear market, the loss on holding Insmed will be expected to be smaller as well. By evaluating Insmed Inc technical indicators, you can presently evaluate if the expected return of 0.16% will be sustainable into the future. Insmed Inc right now retains a risk of 2.88%. Please check out Insmed variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Insmed will be following its current trending patterns.
Insmed Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Insmed Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Insmed may actually be approaching a critical reversion point that can send shares even higher in December 2023. ...more
Forward Dividend Yield 0.014 | Last Split Factor 1:10 | Last Split Date 2011-03-03 |
1 | Insmed A Hidden Gem or Just Modestly Undervalued | 09/05/2023 |
2 | Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference | 09/06/2023 |
3 | Myotonic Dystrophy Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 - Benzinga | 09/25/2023 |
4 | EPS Estimate | 09/29/2023 |
5 | Adult severe asthma registries POR - Dove Medical Press | 10/19/2023 |
6 | EPS Reported | 10/26/2023 |
7 | Soleno Therapeutics Provides Corporate Update and Reports Third ... - StreetInsider.com | 11/07/2023 |
8 | Unclassified Event | 11/13/2023 |
| Begin Period Cash Flow | 716.8 M | |
| Total Cashflows From Investing Activities | -34.6 M |
Insmed |
Insmed Relative Risk vs. Return Landscape
If you would invest 2,208 in Insmed Inc on August 30, 2023 and sell it today you would earn a total of 170.00 from holding Insmed Inc or generate 7.7% return on investment over 90 days. Insmed Inc is currently generating 0.1568% in daily expected returns and assumes 2.8837% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Insmed, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Insmed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insmed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insmed Inc, and traders can use it to determine the average amount a Insmed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0544
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INSM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.88 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Insmed is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insmed by adding it to a well-diversified portfolio.
Insmed Fundamentals Growth
Insmed Stock prices reflect investors' perceptions of the future prospects and financial health of Insmed, and Insmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insmed Stock performance.
| Return On Equity | -14.53 | ||||
| Return On Asset | -0.36 | ||||
| Profit Margin | (2.58) % | ||||
| Current Valuation | 4 B | ||||
| Shares Outstanding | 143.06 M | ||||
| Price To Earning | (8.70) X | ||||
| Price To Book | 48.18 X | ||||
| Price To Sales | 10.89 X | ||||
| Revenue | 245.36 M | ||||
| Gross Profit | 190.23 M | ||||
| EBITDA | (458.21 M) | ||||
| Net Income | (481.53 M) | ||||
| Cash And Equivalents | 554.87 M | ||||
| Cash Per Share | 4.62 X | ||||
| Total Debt | 1.18 B | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (2.02) X | ||||
| Cash Flow From Operations | (400.44 M) | ||||
| Earnings Per Share | (5.29) X | ||||
| Market Capitalization | 3.42 B | ||||
| Total Asset | 1.66 B | ||||
| Retained Earnings | (2.7 B) | ||||
| Working Capital | 1.08 B | ||||
| Current Asset | 28.15 M | ||||
| Current Liabilities | 3.89 M | ||||
About Insmed Performance
To evaluate Insmed Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Insmed generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Insmed Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Insmed Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Insmed's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for 2023 | ||
| Effect of Exchange Rate Changes on Cash | -996 K | -1 M | |
| Return on Investment | (40.91) | (44.14) | |
| Return on Average Assets | (0.40) | (0.43) | |
| Return on Average Equity | (8.67) | (8.90) | |
| Return on Invested Capital | (0.37) | (0.40) | |
| Return on Sales | (1.85) | (1.99) |
Things to note about Insmed Inc performance evaluation
Checking the ongoing alerts about Insmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Insmed Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 245.36 M. Net Loss for the year was (481.53 M) with profit before overhead, payroll, taxes, and interest of 190.23 M. | |
| Insmed Inc currently holds about 554.87 M in cash with (400.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62. | |
| Insmed Inc has a frail financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Soleno Therapeutics Provides Corporate Update and Reports Third ... - StreetInsider.com |
- Analyzing Insmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insmed's stock is overvalued or undervalued compared to its peers.
- Examining Insmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insmed's management team can help you assess the company's leadership.
- Pay attention to analyst opinions and ratings of Insmed's stock. These opinions can provide insight into Insmed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.29) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.167 | Return On Assets (0.36) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.